Evidence for factor IX-independent roles for factor XIa in blood coagulation

A. Matafonov, Q. Cheng, Y. Geng, I. M. Verhamme, O. Umunakwe, Erik Tucker, M. F. Sun, V. Serebrov, Andras Gruber, D. Gailani

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Summary: Background: Factor XIa is traditionally assigned a role in FIX activation during coagulation. However, recent evidence suggests this protease may have additional plasma substrates. Objective: To determine whether FXIa promotes thrombin generation and coagulation in plasma in the absence of FIX, and to determine whether FXI-deficiency produces an antithrombotic effect in mice independently of FIX. Methods: FXIa, FXIa variants and anti-FXIa antibodies were tested for their effects on plasma coagulation and thrombin generation in the absence of FIX, and for their effects on the activation of purified coagulation factors. Mice with combined FIX and FXI deficiency were compared with mice lacking either FIX or FXI in an arterial thrombosis model. Results: In FIX-deficient plasma, FXIa induced thrombin generation, and anti-FXIa antibodies prolonged clotting times. This process involved FXIa-mediated conversion of FX and FV to their active forms. Activation of FV by FXIa required the A3 domain on the FXIa heavy chain, whereas activation of FX did not. FX activation by FXIa, unlike FIX activation, was not a calcium-dependent process. Mice lacking both FIX and FXI were more resistant to ferric chloride-induced carotid artery occlusion than FXI-deficient or FIX-deficient mice. Conclusion: In addition to its predominant role as an activator of FIX, FXIa may contribute to coagulation by activating FX and FV. As the latter reactions do not require calcium, they may make important contributions to in vitro clotting triggered by contact activation. The reactions may be relevant to FXIa's roles in hemostasis and in promoting thrombosis.

Original languageEnglish (US)
Pages (from-to)2118-2127
Number of pages10
JournalJournal of Thrombosis and Haemostasis
Volume11
Issue number12
DOIs
StatePublished - Dec 2013

Fingerprint

Factor XIa
Factor IX
Blood Coagulation
Thrombin
Anti-Idiotypic Antibodies
Thrombosis
Calcium
Blood Coagulation Factors
Hemostasis
Carotid Arteries
Peptide Hydrolases

Keywords

  • Factor IX
  • Factor V
  • Factor X
  • Factor XI
  • Factor XIa

ASJC Scopus subject areas

  • Hematology
  • Medicine(all)

Cite this

Matafonov, A., Cheng, Q., Geng, Y., Verhamme, I. M., Umunakwe, O., Tucker, E., ... Gailani, D. (2013). Evidence for factor IX-independent roles for factor XIa in blood coagulation. Journal of Thrombosis and Haemostasis, 11(12), 2118-2127. https://doi.org/10.1111/jth.12435

Evidence for factor IX-independent roles for factor XIa in blood coagulation. / Matafonov, A.; Cheng, Q.; Geng, Y.; Verhamme, I. M.; Umunakwe, O.; Tucker, Erik; Sun, M. F.; Serebrov, V.; Gruber, Andras; Gailani, D.

In: Journal of Thrombosis and Haemostasis, Vol. 11, No. 12, 12.2013, p. 2118-2127.

Research output: Contribution to journalArticle

Matafonov, A, Cheng, Q, Geng, Y, Verhamme, IM, Umunakwe, O, Tucker, E, Sun, MF, Serebrov, V, Gruber, A & Gailani, D 2013, 'Evidence for factor IX-independent roles for factor XIa in blood coagulation', Journal of Thrombosis and Haemostasis, vol. 11, no. 12, pp. 2118-2127. https://doi.org/10.1111/jth.12435
Matafonov, A. ; Cheng, Q. ; Geng, Y. ; Verhamme, I. M. ; Umunakwe, O. ; Tucker, Erik ; Sun, M. F. ; Serebrov, V. ; Gruber, Andras ; Gailani, D. / Evidence for factor IX-independent roles for factor XIa in blood coagulation. In: Journal of Thrombosis and Haemostasis. 2013 ; Vol. 11, No. 12. pp. 2118-2127.
@article{f0943b8536cf4d2b96e69dac3f38849c,
title = "Evidence for factor IX-independent roles for factor XIa in blood coagulation",
abstract = "Summary: Background: Factor XIa is traditionally assigned a role in FIX activation during coagulation. However, recent evidence suggests this protease may have additional plasma substrates. Objective: To determine whether FXIa promotes thrombin generation and coagulation in plasma in the absence of FIX, and to determine whether FXI-deficiency produces an antithrombotic effect in mice independently of FIX. Methods: FXIa, FXIa variants and anti-FXIa antibodies were tested for their effects on plasma coagulation and thrombin generation in the absence of FIX, and for their effects on the activation of purified coagulation factors. Mice with combined FIX and FXI deficiency were compared with mice lacking either FIX or FXI in an arterial thrombosis model. Results: In FIX-deficient plasma, FXIa induced thrombin generation, and anti-FXIa antibodies prolonged clotting times. This process involved FXIa-mediated conversion of FX and FV to their active forms. Activation of FV by FXIa required the A3 domain on the FXIa heavy chain, whereas activation of FX did not. FX activation by FXIa, unlike FIX activation, was not a calcium-dependent process. Mice lacking both FIX and FXI were more resistant to ferric chloride-induced carotid artery occlusion than FXI-deficient or FIX-deficient mice. Conclusion: In addition to its predominant role as an activator of FIX, FXIa may contribute to coagulation by activating FX and FV. As the latter reactions do not require calcium, they may make important contributions to in vitro clotting triggered by contact activation. The reactions may be relevant to FXIa's roles in hemostasis and in promoting thrombosis.",
keywords = "Factor IX, Factor V, Factor X, Factor XI, Factor XIa",
author = "A. Matafonov and Q. Cheng and Y. Geng and Verhamme, {I. M.} and O. Umunakwe and Erik Tucker and Sun, {M. F.} and V. Serebrov and Andras Gruber and D. Gailani",
year = "2013",
month = "12",
doi = "10.1111/jth.12435",
language = "English (US)",
volume = "11",
pages = "2118--2127",
journal = "Journal of Thrombosis and Haemostasis",
issn = "1538-7933",
publisher = "Wiley-Blackwell",
number = "12",

}

TY - JOUR

T1 - Evidence for factor IX-independent roles for factor XIa in blood coagulation

AU - Matafonov, A.

AU - Cheng, Q.

AU - Geng, Y.

AU - Verhamme, I. M.

AU - Umunakwe, O.

AU - Tucker, Erik

AU - Sun, M. F.

AU - Serebrov, V.

AU - Gruber, Andras

AU - Gailani, D.

PY - 2013/12

Y1 - 2013/12

N2 - Summary: Background: Factor XIa is traditionally assigned a role in FIX activation during coagulation. However, recent evidence suggests this protease may have additional plasma substrates. Objective: To determine whether FXIa promotes thrombin generation and coagulation in plasma in the absence of FIX, and to determine whether FXI-deficiency produces an antithrombotic effect in mice independently of FIX. Methods: FXIa, FXIa variants and anti-FXIa antibodies were tested for their effects on plasma coagulation and thrombin generation in the absence of FIX, and for their effects on the activation of purified coagulation factors. Mice with combined FIX and FXI deficiency were compared with mice lacking either FIX or FXI in an arterial thrombosis model. Results: In FIX-deficient plasma, FXIa induced thrombin generation, and anti-FXIa antibodies prolonged clotting times. This process involved FXIa-mediated conversion of FX and FV to their active forms. Activation of FV by FXIa required the A3 domain on the FXIa heavy chain, whereas activation of FX did not. FX activation by FXIa, unlike FIX activation, was not a calcium-dependent process. Mice lacking both FIX and FXI were more resistant to ferric chloride-induced carotid artery occlusion than FXI-deficient or FIX-deficient mice. Conclusion: In addition to its predominant role as an activator of FIX, FXIa may contribute to coagulation by activating FX and FV. As the latter reactions do not require calcium, they may make important contributions to in vitro clotting triggered by contact activation. The reactions may be relevant to FXIa's roles in hemostasis and in promoting thrombosis.

AB - Summary: Background: Factor XIa is traditionally assigned a role in FIX activation during coagulation. However, recent evidence suggests this protease may have additional plasma substrates. Objective: To determine whether FXIa promotes thrombin generation and coagulation in plasma in the absence of FIX, and to determine whether FXI-deficiency produces an antithrombotic effect in mice independently of FIX. Methods: FXIa, FXIa variants and anti-FXIa antibodies were tested for their effects on plasma coagulation and thrombin generation in the absence of FIX, and for their effects on the activation of purified coagulation factors. Mice with combined FIX and FXI deficiency were compared with mice lacking either FIX or FXI in an arterial thrombosis model. Results: In FIX-deficient plasma, FXIa induced thrombin generation, and anti-FXIa antibodies prolonged clotting times. This process involved FXIa-mediated conversion of FX and FV to their active forms. Activation of FV by FXIa required the A3 domain on the FXIa heavy chain, whereas activation of FX did not. FX activation by FXIa, unlike FIX activation, was not a calcium-dependent process. Mice lacking both FIX and FXI were more resistant to ferric chloride-induced carotid artery occlusion than FXI-deficient or FIX-deficient mice. Conclusion: In addition to its predominant role as an activator of FIX, FXIa may contribute to coagulation by activating FX and FV. As the latter reactions do not require calcium, they may make important contributions to in vitro clotting triggered by contact activation. The reactions may be relevant to FXIa's roles in hemostasis and in promoting thrombosis.

KW - Factor IX

KW - Factor V

KW - Factor X

KW - Factor XI

KW - Factor XIa

UR - http://www.scopus.com/inward/record.url?scp=84889652258&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84889652258&partnerID=8YFLogxK

U2 - 10.1111/jth.12435

DO - 10.1111/jth.12435

M3 - Article

VL - 11

SP - 2118

EP - 2127

JO - Journal of Thrombosis and Haemostasis

JF - Journal of Thrombosis and Haemostasis

SN - 1538-7933

IS - 12

ER -